Search Results 121-130 of 17202 for fibrosis quistica

1. A Study Evaluating The Efficacy And Safety Of Pegozafermin In Participants With MASH And Fibrosis (ENLIGHTEN-Fibrosis) - Mayo Clinic

   The study will assess the efficacy and safety of 2 dose regimens of pegozafermin compared to placebo for the treatment of liver fibrosis stage F2 or F3 in adult ...

2. Relationship Between Changes in Body Image or Body Acceptance Brought About by Treatment Advances and Mental Health in Cystic Fibrosis - Mayo Clinic

   The purpose of this study is to examine perceived body image or body acceptance and mental health in adults with Cystic Fibrosis (CF) in the setting of highly ...

3. A Study to Determine if Oral Glucose Tolerance Testing can Improve Screening Compliance in Cystic Fibrosis - Mayo Clinic

   Clinical Trials · A Study to Determine if Oral Glucose Tolerance Testing can Improve Screening Compliance in Cystic Fibrosis · More about research at Mayo Clinic.

4. Open-Label Study of the Long Term Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF) - Mayo Clinic

   Open-Label Study of the Long Term Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF) · Overview · Participation eligibility · Participating ...

5. A Trial to Evaluate the Safety of Long Term Treatment With Nintedanib in Patients With Scleroderma Related Lung Fibrosis - Mayo Clinic

   A Trial to Evaluate the Safety of Long Term Treatment With Nintedanib in Patients With Scleroderma Related Lung Fibrosis · Overview · Participation eligibility.

6. A Phase 2 Study to See if Simtuzumab (GS-6624) is Safe and Works in Idiopathic Pulmonary Fibrosis (IPF) - Mayo Clinic

   The purpose of this study is to determine if Simtuzumab (GS-6624) is safe and effective in treating Idiopathic Pulmonary Fibrosis. Participation eligibility.

7. Safety And Efficacy Of A Lysophosphatidic Acid Receptor Antagonist In Idiopathic Pulmonary Fibrosis - Mayo Clinic

   ... fibrosis (IPF). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...

8. A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF) - Mayo Clinic

   Clinical Trials · A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF) · More about research at Mayo ...

9. A Study To Assess The Feasibility Of Folate Scan In Patients With Idiopathic Pulmonary Fibrosis - Mayo Clinic

   The purpose of this study is to assess the feasibility of Folate scan in patients with Idiopathic Pulmonary Fibrosis (IPF). Participation eligibility.

10. A Study to Evaluate Low Dose Chest CT vs. Standard CT in Cystic Fibrosis Patients - Mayo Clinic

    A Study to Evaluate Low Dose Chest CT vs. Standard CT in Cystic Fibrosis Patients · Overview · Participation eligibility · Participating Mayo Clinic locations.